Open Access

Inhibition of autophagy enhances adenosine‑induced apoptosis in human hepatoblastoma HepG2 cells

  • Authors:
    • Xiao‑Tao Zhou
    • Ze‑Jin Pu
    • Li‑Xuan Liu
    • Guo‑Ping Li
    • Jia‑Lin Feng
    • Hua‑Chen Zhu
    • Ling‑Fei Wu
  • View Affiliations

  • Published online on: November 30, 2018     https://doi.org/10.3892/or.2018.6899
  • Pages: 829-838
  • Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In cancer research, autophagy acts as a double‑edged sword: it increases cell viability or induces cell apoptosis depending upon the cell context and functional status. Recent studies have shown that adenosine (Ado) has cytotoxic effects in many tumors. However, the role of autophagy in Ado‑induced apoptosis is still poorly understood. In the present study, Ado‑induced apoptotic death and autophagy in hepatoblastoma HepG2 cells was investigated and the relationship between autophagy and apoptosis was identified. In the present study, it was demonstrated that Ado inhibited HepG2 cell growth in a time‑ and concentration‑dependent manner and activated endoplasmic reticulum (ER) stress, as indicated by G0/G1 cell cycle arrest, the increased mRNA and protein levels of GRP78/BiP, PERK, ATF4, CHOP, cleaved caspase‑3, cytochrome c and the loss of mitochon­drial membrane potential (ΔΨm). Ado also induced autophagic flux, revealed by the increased expression of the autophagy marker microtubule‑associated protein 1 light chain 3‑II (LC3‑II), Beclin‑1, autophagosomes, and the degradation of p62, as revealed by western blot analysis and macrophage‑derived chemokine (MDC) staining. Blocking autophagy using LY294002 notably entrenched Ado‑induced growth inhibition and cell apoptosis, as demonstrated with the increased expression of cytochrome c and p62, and the decreased expression of LC3‑II. Conversely, the autophagy inducer rapamycin alleviated Ado‑induced apoptosis and markedly increased the ΔΨm. Moreover, knockdown of AMPK with si‑AMPK partially abolished Ado‑induced ULK1 activation and mTOR inhibition, and thus reinforced CHOP expression and Ado‑induced apoptosis. These results indicated that Ado‑induced ER stress resulted in apoptosis and autophagy concurrently. The AMPK/mTOR/ULK1 signaling pathway played a protective role in the apoptotic procession. Inhibition of autophagy may effectively enhance the anticancer effect of Ado in human hepatoblastoma HepG2 cells.
View Figures
View References

Related Articles

Journal Cover

February-2019
Volume 41 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhou XT, Pu ZJ, Liu LX, Li GP, Feng JL, Zhu HC and Wu LF: Inhibition of autophagy enhances adenosine‑induced apoptosis in human hepatoblastoma HepG2 cells. Oncol Rep 41: 829-838, 2019.
APA
Zhou, X., Pu, Z., Liu, L., Li, G., Feng, J., Zhu, H., & Wu, L. (2019). Inhibition of autophagy enhances adenosine‑induced apoptosis in human hepatoblastoma HepG2 cells. Oncology Reports, 41, 829-838. https://doi.org/10.3892/or.2018.6899
MLA
Zhou, X., Pu, Z., Liu, L., Li, G., Feng, J., Zhu, H., Wu, L."Inhibition of autophagy enhances adenosine‑induced apoptosis in human hepatoblastoma HepG2 cells". Oncology Reports 41.2 (2019): 829-838.
Chicago
Zhou, X., Pu, Z., Liu, L., Li, G., Feng, J., Zhu, H., Wu, L."Inhibition of autophagy enhances adenosine‑induced apoptosis in human hepatoblastoma HepG2 cells". Oncology Reports 41, no. 2 (2019): 829-838. https://doi.org/10.3892/or.2018.6899